Document Detail

Modulation of vascular cyclic nucleotide phosphodiesterases by cyclic GMP: role in vasodilatation.
MedLine Citation:
PMID:  8293765     Owner:  NLM     Status:  MEDLINE    
Vascular smooth muscle contraction is modulated by an increase in cyclic guanosine monophosphate (cyclic GMP) subsequent to nitric oxide production by endothelial cells. The participation in this vasodilatation of specific cyclic adenosine monophosphate (cyclic AMP) phosphodiesterase (PDE) forms differentially sensitive to cyclic GMP is unclear. Chromatographic separation and pharmacological characterization show that the specific cyclic AMP PDE of endothelial cells is of the PDE IV subtype, known to be insensitive to cyclic GMP, whereas cyclic AMP PDEs of vascular smooth muscle are both cyclic GMP-sensitive and -insensitive (subtypes PDE III and PDE IV, respectively). The role of these PDE forms in the modulation of vascular contraction was investigated in rat aorta with and without endothelium by using specific inhibitors of PDE III and PDE IV as relaxing agents. PDE III inhibitors (milrinone, CI 930, SK&F 94120 and LY 195115) similarly relax rat aorta with and without endothelium and their potencies are not modified by NG-monomethyl-L-arginine (L-NMMA, 300 microM) or L-arginine (1 mM). However, PDE IV inhibitors (rolipram and denbufylline) only induce relaxation of aorta with endothelium, this relaxation being reversed by addition of L-NMMA and restored by addition of L-arginine. Relaxation studies performed with PDE IV inhibitors in the presence of low concentration of agents that increase cyclic AMP or cyclic GMP, clearly show that PDE IV inhibitor potencies are markedly increased by cyclic GMP elevating agents, by PDE III inhibitors and by the presence of functional endothelium.(ABSTRACT TRUNCATED AT 250 WORDS)
C Lugnier; N Komas
Related Documents :
2105095 - Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of ara...
10101745 - Pituitary adenylate cyclase activating peptide induces cgmp-mediated relaxation in guin...
23730995 - Effect of gm-csf on neutrophil function in idiopathic bronchiectasis.
10072115 - Danazol therapy in cyclic acquired amegakaryocytic thrombocytopenic purpura: a case rep...
25117655 - Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytoki...
11372675 - Plasma levels of total and free tissue factor pathway inhibitor (tfpi) as individual ph...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European heart journal     Volume:  14 Suppl I     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-03-03     Completed Date:  1994-03-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  141-8     Citation Subset:  IM    
Laboratoire de Pharmacologie Cellulaire et Moléculaire, CNRS URA 600, Université Louis Pasteur de Strasbourg, Illkirch, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aorta / enzymology
Cyclic AMP / physiology
Cyclic GMP / physiology*
Endothelium, Vascular / enzymology*
Isoenzymes / analysis,  chemistry,  physiology*
Muscle, Smooth, Vascular / enzymology*
Phosphoric Diester Hydrolases / analysis,  chemistry,  physiology*
Vasodilation / physiology*
Reg. No./Substance:
0/Isoenzymes; 60-92-4/Cyclic AMP; 7665-99-8/Cyclic GMP; EC 3.1.4.-/Phosphoric Diester Hydrolases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells.
Next Document:  Control of vascular tone by renin and angiotensin in cardiovascular disease.